Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contribution to rabies prevention.

P Sureau1

  • 1Institut Pasteur, Paris, France.

Vaccine
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

European researchers rapidly developed safer, more potent rabies vaccines after World War II. Cell culture vaccines and recombinant vaccines for wildlife and human immunization represent significant advancements in rabies control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in France.

The American journal of tropical medicine and hygiene·1995
Same author

[Post-exposure antirabies vaccination. Early serological response to vaccine cultivated on VERO cells using a reduced 2-1-1 schedule].

Presse medicale (Paris, France : 1983)·1994
Same author

Hantavirus epidemic in Europe, 1993.

Lancet (London, England)·1994
Same author

[Reduced vaccination schedules: effect of the combination with serotherapy on the immunogenicity of rabies vaccines].

Presse medicale (Paris, France : 1983)·1992
Same author

[Efficacy and immunogeneity of reduced rabies vaccination schedules in subjects in contact with rabies-infected animals].

Presse medicale (Paris, France : 1983)·1992
Same author

[Rabies encephalomyelitis with myocarditis and pancreatitis. Report on a case recently imported into France].

Annales de pathologie·1992

Area of Science:

  • Veterinary Medicine
  • Virology
  • Vaccinology

Background:

  • Post-WWII fox rabies outbreak in Europe necessitated improved rabies vaccines.
  • First-generation nerve tissue vaccines were less potent and safe.
  • Need for enhanced immunization strategies against wildlife-transmitted rabies.

Purpose of the Study:

  • To detail the evolution of rabies vaccine generations.
  • To highlight advancements in vaccine production and application.
  • To address the challenge of rabies transmission from wild animals.

Main Methods:

  • Development of cell culture-based vaccines (second generation).
  • Industrial-scale bioreactor production of cell line vaccines.
  • Application of recombinant vaccines (third generation) in wildlife and human trials.

Related Experiment Videos

Main Results:

  • Second-generation vaccines offered improved potency and safety.
  • Recombinant vaccinia-rabies glycoprotein vaccines are used for wildlife immunization.
  • Canarypox recombinant vaccines show promise for human immunization.

Conclusions:

  • European collaboration rapidly advanced rabies vaccine technology.
  • Cell culture and recombinant vaccines represent significant progress in rabies prevention.
  • Ongoing development offers enhanced protection for humans and animals.